Literature DB >> 21515661

Cell-based therapies in pulmonary hypertension: who, what, and when?

Susan Majka, Ellen Burnham, Kurt R Stenmark.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21515661      PMCID： PMC3129904          DOI： 10.1152/ajplung.00118.2011

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN： 1040-0605            Impact factor:   5.464


× No keyword cloud information.
  25 in total

Review 1.  A meta-analysis of trials of pulmonary hypertension: a clinical condition looking for drugs and research methodology.

Authors:  Alejandro Macchia; Roberto Marchioli; RosaMaria Marfisi; Marco Scarano; Giacomo Levantesi; Luigi Tavazzi; Gianni Tognoni
Journal:  Am Heart J       Date:  2007-06       Impact factor: 4.749

2.  Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice.

Authors:  Naveen Gupta; Xiao Su; Boris Popov; Jae Woo Lee; Vladimir Serikov; Michael A Matthay
Journal:  J Immunol       Date:  2007-08-01       Impact factor: 5.422

Review 3.  Updated clinical classification of pulmonary hypertension.

Authors:  Gérald Simonneau; Ivan M Robbins; Maurice Beghetti; Richard N Channick; Marion Delcroix; Christopher P Denton; C Gregory Elliott; Sean P Gaine; Mark T Gladwin; Zhi-Cheng Jing; Michael J Krowka; David Langleben; Norifumi Nakanishi; Rogério Souza
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

Review 4.  Diagnosis and assessment of pulmonary arterial hypertension.

Authors:  David B Badesch; Hunter C Champion; Miguel Angel Gomez Sanchez; Marius M Hoeper; James E Loyd; Alessandra Manes; Michael McGoon; Robert Naeije; Horst Olschewski; Ronald J Oudiz; Adam Torbicki
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

5.  Bone marrow-derived mesenchymal stem cells in repair of the injured lung.

Authors:  Mauricio Rojas; Jianguo Xu; Charles R Woods; Ana L Mora; Willy Spears; Jesse Roman; Kenneth L Brigham
Journal:  Am J Respir Cell Mol Biol       Date:  2005-05-12       Impact factor: 6.914

6.  Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease.

Authors:  Yidan D Zhao; David W Courtman; Yupu Deng; Lakshmi Kugathasan; Qiuwang Zhang; Duncan J Stewart
Journal:  Circ Res       Date:  2005-02-03       Impact factor: 17.367

7.  Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury.

Authors:  Luis A Ortiz; Maria Dutreil; Cheryl Fattman; Amitabh C Pandey; German Torres; Kristina Go; Donald G Phinney
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-14       Impact factor: 11.205

8.  Sustained endothelial progenitor cell dysfunction after chronic hypoxia-induced pulmonary hypertension.

Authors:  Glenn Marsboom; Peter Pokreisz; Olivier Gheysens; Pieter Vermeersch; Hilde Gillijns; Marijke Pellens; Xiaoshun Liu; Désiré Collen; Stefan Janssens
Journal:  Stem Cells       Date:  2008-02-07       Impact factor: 6.277

9.  Effects of bone marrow-derived cells on monocrotaline- and hypoxia-induced pulmonary hypertension in mice.

Authors:  William Raoul; Orianne Wagner-Ballon; Guitanouch Saber; Anne Hulin; Elisabeth Marcos; Stéphane Giraudier; William Vainchenker; Serge Adnot; Saadia Eddahibi; Bernard Maitre
Journal:  Respir Res       Date:  2007-01-30

Review 10.  A meta-analysis of randomized controlled trials in pulmonary arterial hypertension.

Authors:  Nazzareno Galiè; Alessandra Manes; Luca Negro; Massimiliano Palazzini; Maria Letizia Bacchi-Reggiani; Angelo Branzi
Journal:  Eur Heart J       Date:  2009-01-20       Impact factor: 29.983
View more
  3 in total

Review 1.  Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.

Authors:  Daniel J Weiss
Journal:  Ann Am Thorac Soc       Date:  2013-10

2.  Endothelial indoleamine 2,3-dioxygenase protects against development of pulmonary hypertension.

Authors:  Yongguang Xiao; Helen Christou; Li Liu; Gary Visner; S Alex Mitsialis; Stella Kourembanas; Hanzhong Liu
Journal:  Am J Respir Crit Care Med       Date:  2013-08-15       Impact factor: 21.405

3.  New models of pulmonary hypertension based on VEGF receptor blockade-induced endothelial cell apoptosis.

Authors:  Mark R Nicolls; Shiro Mizuno; Laima Taraseviciene-Stewart; Laszlo Farkas; Jennnifer I Drake; Aysar Al Husseini; Jose G Gomez-Arroyo; Norbert F Voelkel; Herman J Bogaard
Journal:  Pulm Circ       Date:  2012-10       Impact factor: 3.017
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.